Incidence of acute bilirubin encephalopathy · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
Bilirubin (µmol/L) · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
Proportion of infants who required exchange transfusion · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
Intravenous fluid supplementation may leads to lower proportion of infants who required exchange transfusion compared with no fluid supplementation (low certainty).
1 finding from 1 review
Frequency of breastfeeding per day · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
Number of infants with abnormal neurological signs · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
Bilirubin (µmol/L) · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
Rate of change in bilirubin (μmol/L/hour): during the first 4 hours of admission · newborn infants with unconjugated hyperbilirubinaemia undergoing phototherapy
1 finding from 1 review
Intervention not reported
Bloodstream infection (during intervention period) · newborn infants
The intervention showed no clear difference in bloodstream infection (during intervention period) (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality (up to hospital discharge) · newborn infants
The intervention showed no clear difference in all‐cause mortality (up to hospital discharge) (low certainty).
1 finding from 1 review
Intervention not reported
Catheter‐associated thrombosis necessitating removal of catheter (during intervention period) · newborn infants
The intervention showed no clear difference in catheter‐associated thrombosis necessitating removal of catheter… (low certainty).
1 finding from 1 review
All‐cause mortality during hospital stay · neonates with mechanical ventilation
Clonidine showed no clear difference in all‐cause mortality during initial hospitalization compared with placebo (low certainty).
1 finding from 1 review
aOne study and few events · neonates with mechanical ventilation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Visual acuity at 12 months post‐term (log/cycles/degree) · Preterm infants on enteral feed
1 finding from 1 review
no estimate extracted
82 participants
Low
Intervention not reported
Bayley MDI at 12 months post‐term · Preterm infants on enteral feed
The intervention showed no clear difference in bayley MDI at 12 months post‐term (low certainty).
1 finding from 1 review
Intervention not reported
Bayley PDI at 12 months post‐term · Preterm infants on enteral feed
The intervention showed no clear difference in bayley PDI at 12 months post‐term (low certainty).
1 finding from 1 review
Intervention not reported
Weight at 12 months post‐term (kg) · Preterm infants on enteral feed
The intervention showed no clear difference in weight at 12 months post‐term (kg) (low certainty).
1 finding from 1 review
Intervention not reported
Length at 12 months post‐term (cm) · Preterm infants on enteral feed
The intervention showed no clear difference in length at 12 months post‐term (cm) (low certainty).
1 finding from 1 review
Intervention not reported
Head circumference at 12 months post‐term (cm) · Preterm infants on enteral feed
The intervention showed no clear difference in head circumference at 12 months post‐term (cm) (low certainty).
1 finding from 1 review
Neonatal mortality · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in neonatal death compared with no supplementation (moderate certainty).
1 finding from 1 review
Chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in chronic lung disease (oxygen use at 28 days in survivors) compared with no supplementation (moderate certainty).
2 findings from 1 review